Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6428024 | 1.00 | HRH1 (0.50) | HRH1LMNASMN1; SMN2MAPTLIN28A | |
| SCHEMBL27986483 | 0.87 | HRH1 (0.40) | HRH1LMNASMN1; SMN2MAPTLIN28A | |
| SCHEMBL21160375 | 0.86 | HRH1 (0.46) | HRH1LMNASMN1; SMN2MAPTLIN28A | |
| SCHEMBL28985180 | 0.83 | HRH1 (0.50) | HRH1LMNASMN1; SMN2MAPTLIN28A | |
| SCHEMBL10810253 | 0.83 | HRH1 (0.50) | HRH1LMNASMN1; SMN2MAPTLIN28A | |
| SCHEMBL28985167 | 0.83 | HRH1 (0.50) | HRH1LMNASMN1; SMN2MAPTLIN28A | |
| SCHEMBL6666747 | 0.83 | — | — | |
| SCHEMBL5442492 | 0.80 | HRH1 (0.57) | HRH1LMNASMN1; SMN2MAPTLIN28A | |
| SCHEMBL6159415 | 0.79 | HRH1 (0.45) | HRH1LMNASMN1; SMN2MAPTLIN28A | |
| SCHEMBL16992895 | 0.79 | HRH1 (0.45) | HRH1LMNASMN1; SMN2MAPTLIN28A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 940 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117756841-A | Preparation method and application of two-dimensional aromatic D-J type halide perovskite with photocatalytic activity | 华东理工大学 | 2024-03-26 | — | — | CN | claimed |
| CN-117362259-A | 6-azo phenyl coumarin-3-formamide compound, and preparation method and application thereof | 南京林业大学 | 2024-01-09 | — | — | CN | claimed |
| CN-117229523-A | Ultrathin porphyrin-based benzamide derivative HOFs nano material and preparation method and application thereof | 河南大学 | 2023-12-15 | — | — | CN | claimed |
| CN-107880545-B | Resin composition, method for producing cured product, and cured product | 东京应化工业株式会社 | 2022-03-18 | — | — | CN | claimed |
| US-9851636-B2 | Materials and methods for improved photoresist performance | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2017-12-26 | — | — | US | claimed |
| CN-103641820-B | Tetrazolium imines coumarins copper ion fluorescence probe and preparation method thereof | NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2016-01-20 | — | — | CN | claimed |
| CN-103641820-A | Tetrazolium imine coumarins copper ion fluorescence probe and preparation method thereof | UNIV NANJING SCIENCE & TECH | 2014-03-19 | — | — | CN | claimed |
| EP-1117002-B1 | Negative-working resist composition | FUJIFILM CORP (JP) | 2010-04-14 | — | — | EP | claimed |
| US-20060264357-A1 | Capillary membrane stabilization and reduction of tissue injury through use of biodegradable macromolecules with antioxidants and/or other chemicals | ZIKRIA BASHIR A | 2006-11-23 | — | — | US | claimed |
| US-20060127387-A1 | Compositions based on polysaccharides and protein C and methods of using the same for preventing and treating sepsis and other conditions | ZIKRIA BASHIR A | 2006-06-15 | — | — | US | claimed |
| EP-1343497-A4 | $g(D)?2 ,-1,2,3-TRIAZOLINE ANTICONVULSANTS AND THEIR ACTIVE METABOLITE ANALOGUES, THE AMINOALKYLPYRIDINES, ARE EXCITATORY AMINO ACID ANTAGONISTS AND ANTIISCHEMIC AGENTS, USEFUL IN THE TREATMENT OF CEREBRAL ISCHEMIA RESULTING FROM STROKE | K AND K BIOSCIENCES INC (US) | 2005-01-26 | — | — | EP | claimed |
| US-20040073039-A1 | Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke | K AND K BIOSCIENCES, INC. | 2004-04-15 | — | — | US | claimed |
| US-6699635-B1 | SUITABLE FOR THE CASES WHEREIN FAR ULTRAVIOLET RAYS HAVING WAVELENGTHS OF 250 NM OR SHORTER ARE USED AS EXPOSURE LIGHT | FUJI PHOTO FILM CO., LTD. (JP) | 2004-03-02 | — | — | US | claimed |
| US-6673512-B1 | PHOTORESISTS COMPRISING HOMO(CO)POLYCARBONS, ACID GENERATORS, CURING AGENTS AND BASES, USED TO FORM MINIATURIZED PATTERNS ON SEMICONDUCTORS USING X-RAYS OR RADIATION BEAMS; HIGH SENSITIVITY AND RESOLUTION | FUJI PHOTO FILM CO., LTD. (JP) | 2004-01-06 | — | — | US | claimed |
| EP-1343497-A1 | $g(D)?2 ,-1,2,3-TRIAZOLINE ANTICONVULSANTS AND THEIR ACTIVE METABOLITE ANALOGUES, THE AMINOALKYLPYRIDINES, ARE EXCITATORY AMINO ACID ANTAGONISTS AND ANTIISCHEMIC AGENTS, USEFUL IN THE TREATMENT OF CEREBRAL ISCHEMIA RESULTING FROM STROKE | K and K Biosciences, Inc. (US) | 2003-09-17 | — | — | EP | claimed |
| US-20020111371-A1 | Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke | K AND K BIOSCIENCES, INC. | 2002-08-15 | — | — | US | claimed |
| WO-2002036119-A1 | Δ2,-1,2,3-TRIAZOLINE ANTICONVULSANTS AND THEIR ACTIVE METABOLITE ANALOGUES, THE AMINOALKYLPYRIDINES, ARE EXCITATORY AMINO ACID ANTAGONISTS AND ANTIISCHEMIC AGENTS, USEFUL IN THE TREATMENT OF CEREBRAL ISCHEMIA RESULTING FROM STROKE | K AND K BIOSCIENCES, INC. (US) | 2002-05-10 | — | — | WO | claimed |
| US-6083964-A | ANTIEPILEPTIC PHARMACEUTICAL COMPOSITIONS WITH NO NEUROTOXICITY | K AND K BIOSCIENCES, INC. (US) | 2000-07-04 | — | — | US | claimed |
| US-5545307-A | Process for patterned electroplating | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1996-08-13 | — | — | US | claimed |
| US-4292185-A | COMPRISING A DIENE-MODIFIED MONOOLEFINIC POLYMER REACTED WITH CHLOROSULFONYL ISOCYANATE AND THEN WITH AN AMINE | ROHM AND HAAS COMPANY (US) | 1981-09-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040073039-A1 | Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke | SIGMAR1, GRM1, GRIN2C | HRH1 149/4885LMNA 4177/4885SMN1; SMN2 2473/4885 |
| US-20060127387-A1 | Compositions based on polysaccharides and protein C and methods of using the same for preventing and treating sepsis and other conditions | PROC, PYGM, FGB | HRH1 2981/4885LMNA 682/4885SMN1; SMN2 1679/4885 |
| US-20020111371-A1 | Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke | SIGMAR1, GRM1, GRIN2C | HRH1 149/4885LMNA 4177/4885SMN1; SMN2 2473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.